HazMat Fee + There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) |
| Excepted Quantity | USD 0.00 |
| Limited Quantity | USD 15-60 |
| Inaccessible (Haz class 6.1), Domestic | USD 80+ |
| Inaccessible (Haz class 6.1), International | USD 150+ |
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 靶点 |
|
| 描述 | Niflumic acid, a drug used for joint and muscular pain, affected Ca²⁺ signaling in different models. In MG63 cells, niflumic acid induced [Ca²⁺]i rises by evoking PLC-dependent (phospholipase C) Ca²⁺ release from the endoplasmic reticulum, and Ca²⁺ entry via PKC-sensitive (protein kinase C) store-operated Ca²⁺ entry. Niflumic acid also induced Ca²⁺-independent cell death[3]. Niflumic acid (10 and 30 mM) also inhibited the noradrenaline-induced increase in perfusion pressure and 30 mM niflumic acid reduced the pressor response to 1 nmol noradrenaline by 34 +/- 6%. The increases in perfusion elicited by 5-HT (0.3 and 3 nmol) were reduced by niflumic acid (10 and 30 mM) in a concentration-dependent manner and 30 mM niflumic acid inhibited responses to 0.3 and 3 nmol 5-HT by, respectively, 49 +/- 8% and 50 +/- 7%. Niflumic acid selectively reduces a component of noradrenaline- and 5-HT-induced pressor responses by inhibiting a mechanism which leads to the opening of voltage-gated calcium channels[4]. Niflumic acid restored core and associated symptoms of peripheral neuropathy by suppressing oxidative-nitrosative stress, inflammatory cytokines (TNF-α, IL-1β) and TRPV1 level in stavudine-induced neuropathic pain in rats. Pharmacological efficacy of niflumic acid (20 mg/kg) was equivalent to pregabalin (30 mg/kg) [5]. |
| Concentration | Treated Time | Description | References | |
| Rat aortic smooth muscle cells | 10 µM | 10 min | Niflumic acid did not inhibit contractions induced by KCl (up to 120 mM), which were completely blocked by nifedipine. | Br J Pharmacol. 1996 Jun;118(4):1065-71 |
| CHO cells | 30, 100 µM | 10 s | Niflumic acid inhibited glycine-induced currents mediated by α3 glycine receptors, with higher blocking potency at positive membrane potentials. | Front Mol Neurosci. 2017 May 16;10:125 |
| CHO cells | 10, 30, 100 µM | 10 s | Niflumic acid showed stronger inhibition of glycine-induced currents mediated by α2 glycine receptors, with pronounced voltage dependence. | Front Mol Neurosci. 2017 May 16;10:125 |
| CHO cells | 30, 100, 300 µM | 10 s | Niflumic acid inhibited glycine-induced currents mediated by α1 glycine receptors in a voltage-dependent manner, with higher blocking potency at positive membrane potentials. | Front Mol Neurosci. 2017 May 16;10:125 |
| Rat skeletal muscle fibers | 42 µM (IC50) | 10–15 minutes | Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium. | Br J Pharmacol. 2007 Jan;150(2):235-47 |
| Hypoglossal motoneurons (HMs) in brainstem slices from mice | 100 µM | 1-3 minutes | NFA inhibited the amplitude and frequency of glycinergic synaptic currents, with stronger inhibition in the neonatal group | Front Mol Neurosci. 2018 Nov 13;11:416 |
| Rat aortic smooth muscle cells | 10 µM | 15 min | In Ca-free conditions, niflumic acid did not inhibit the transient contraction induced by 1 μM NA, indicating it does not reduce calcium release from intracellular stores or the sensitivity of the contractile apparatus to calcium. | Br J Pharmacol. 1996 Jun;118(4):1065-71 |
| Rat aortic smooth muscle cells | 10 µM | 15 min | Niflumic acid inhibited contractions induced by brief application of 1 μM NA by 55%. | Br J Pharmacol. 1996 Jun;118(4):1065-71 |
| Rat mesenteric vascular bed smooth muscle cells | 10 and 30 µM | 15 minutes | Niflumic acid inhibited noradrenaline- and 5-HT-induced pressor responses, with 30 μM niflumic acid reducing the pressor response to 1 nmol noradrenaline by 34±6%. | Br J Pharmacol. 1997 Mar;120(5):813-8 |
| Rat stomach fundus smooth muscle cells | 1-30 µM | 15 minutes | Niflumic acid concentration-dependently inhibited 5-HT-induced contractions, reducing to 15.5±6.0% of control at 30 μM. | Br J Pharmacol. 2000 Jun;130(3):678-84 |
| Rat pulmonary artery smooth muscle cells | 50 µM | 2 minutes | NFA significantly increased basal [Ca2+]i and attenuated the caffeine-induced increase in [Ca2+]i. | Br J Pharmacol. 2003 Dec;140(8):1442-50 |
| Xenopus oocytes | 100 µM | 2 to 5 min | NFA increased Kv1.1 current amplitudes by enhancing the channel open probability, causing a hyperpolarizing shift in the voltage dependence of both channel opening and gating charge movement, slowing the OFF-gating current decay. | Proc Natl Acad Sci U S A. 2023 Aug;120(31):e2207978120 |
| HEK293 cells | 50 µM | 24 hours | Niflumic acid (NFA) acted as a pharmacological chaperone, restoring chloride current density of A531V and V947E mutants to levels similar to WT without altering voltage dependence. | Front Pharmacol. 2022 Aug 11;13:958196 |
| Rat aortic smooth muscle cells | 3 µM and 10 µM | 30 min | Niflumic acid reversibly and concentration-dependently inhibited noradrenaline (NA)-induced contractions, with 10 μM niflumic acid inhibiting the maximal contraction by 38%. | Br J Pharmacol. 1996 Jun;118(4):1065-71 |
| BALB/3T3 clone A31 (mouse normal fibroblasts) | 158.8 ± 33.0 µM (IC50) | 72 hours | Evaluation of antiproliferative activity of niflumic acid alone, IC50 value was 158.8 ± 33.0 µM | Int J Mol Sci. 2024 Oct 13;25(20):11015 |
| A172 (glioblastoma) | 143.2 ± 6.5 µM (IC50) | 72 hours | Evaluation of antiproliferative activity of niflumic acid alone, IC50 value was 143.2 ± 6.5 µM | Int J Mol Sci. 2024 Oct 13;25(20):11015 |
| MCC13 (Merkel cell cancer) | 175.4 ± 6.9 µM (IC50) | 72 hours | Evaluation of antiproliferative activity of niflumic acid alone, IC50 value was 175.4 ± 6.9 µM | Int J Mol Sci. 2024 Oct 13;25(20):11015 |
| SK-MEL-3 (melanoma) | 167.1 ± 4.4 µM (IC50) | 72 hours | Evaluation of antiproliferative activity of niflumic acid alone, IC50 value was 167.1 ± 4.4 µM | Int J Mol Sci. 2024 Oct 13;25(20):11015 |
| UM-SCC-17A (head and neck squamous carcinoma) | 310.3 ± 32.6 µM (IC50) | 72 hours | Evaluation of antiproliferative activity of niflumic acid alone, IC50 value was 310.3 ± 32.6 µM | Int J Mol Sci. 2024 Oct 13;25(20):11015 |
| A-431 (epidermoid carcinoma) | 153.3 ± 43.1 µM (IC50) | 72 hours | Evaluation of antiproliferative activity of niflumic acid alone, IC50 value was 153.3 ± 43.1 µM | Int J Mol Sci. 2024 Oct 13;25(20):11015 |
| 5637 (urinary bladder carcinoma) | 103.5 ± 17.1 µM (IC50) | 72 hours | Evaluation of antiproliferative activity of niflumic acid alone, IC50 value was 103.5 ± 17.1 µM | Int J Mol Sci. 2024 Oct 13;25(20):11015 |
| Administration | Dosage | Frequency | Description | References | ||
| Rat | Isolated mesenteric vascular bed | Perfusion | 10 and 30 μM | 15 minutes pre-exposure | Niflumic acid selectively inhibited noradrenaline- and 5-HT-induced pressor responses but did not affect KCl-induced pressor responses. | Br J Pharmacol. 1997 Mar;120(5):813-8 |
| Mice | Kv1.1V408A/+ mouse model | Intraperitoneal injection | 10 mg/kg | Single administration | NFA ameliorated the motor performance of Kv1.1V408A/+ mice, significantly reducing foot slips and missteps on both narrow beam and horizontal ladder tasks. | Proc Natl Acad Sci U S A. 2023 Aug;120(31):e2207978120 |
| Mice | Kir6.2−/− mice | Pancreas perfusion | 100 µM | Single administration | Niflumic acid almost completely blocked cAMP-induced glucose-stimulated insulin secretion | Diabetologia. 2009 May;52(5):863-72 |
| Rats | Chronic hypoxia model | Lung perfusion | 30 μM | Single administration | To evaluate the role of Cl? channels in NS1619-induced pulmonary vasodilation | Lung. 2014 Oct;192(5):811-7 |
| Zebrafish | Zebrafish embryos | Bath application | 500 µM | 30 minutes | Niflumic acid treatment caused bilateral muscle contractions in response to tactile stimulation | Sci Rep. 2020 Aug 19;10(1):13999 |
| Sprague Dawley rats | Steroid-induced Pneumocystis pneumonia model | Intraperitoneal injection | 6 mg/kg/day | Once daily for 4 weeks | NFA caused a significant decrease in total mucus, MUC5AC and mCLCA3 and also, in Pneumocystis-associated inflammation. Most relevant, NFA treatment improved survival at 8 weeks of steroids. | Front Microbiol. 2019 Jul 5;10:1522 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.54mL 0.71mL 0.35mL |
17.72mL 3.54mL 1.77mL |
35.43mL 7.09mL 3.54mL |
|
| CAS号 | 4394-00-7 |
| 分子式 | C13H9F3N2O2 |
| 分子量 | 282.22 |
| SMILES Code | C1=C(C(=NC=C1)NC2=CC(=CC=C2)C(F)(F)F)C(O)=O |
| MDL No. | MFCD00010569 |
| 别名 | 尼氟酸 ;Actol; Nifluril; Niflumic Acid, Donalgin, Flunir, Niflactol, Niflugel, Nifluril; UP83; Donalgin |
| 运输 | 蓝冰 |
| InChI Key | JZFPYUNJRRFVQU-UHFFFAOYSA-N |
| Pubchem ID | 4488 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,2-8°C |
| 溶解方案 |
DMSO: 105 mg/mL(372.05 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1